芒果视频下载

福(fu)安藥業(ye)（集(ji)團）股份有限公司成立(li)于2004年(nian)2月25日，公司位于重(zhong)慶市(shi)長(chang)壽(shou)經(jing)濟技術(shu)開發(fa)區，占地面(mian)積約100畝，建筑面(mian)積3萬余平(ping)方米，注冊資本(ben)11.89億元(yuan)。是長(chang)壽(shou)經(jing)濟技術(shu)開發(fa)區在深(shen)圳創業(ye)板成功上市(shi)的企業(ye)（2011年(nian)3月22日  股票代碼(ma)：300194）。

公(gong)(gong)(gong)司(si)旗下擁有(you)(you)9家全(quan)(quan)(quan)資(zi)及控(kong)股(gu)(gu)子公(gong)(gong)(gong)司(si)，分(fen)別為(wei)(wei)：2008年(nian)(nian)(nian)3月(yue)(yue)成立的(de)(de)(de)(de)(de)從(cong)事(shi)藥(yao)(yao)品研發的(de)(de)(de)(de)(de)全(quan)(quan)(quan)資(zi)子公(gong)(gong)(gong)司(si)福(fu)安(an)(an)藥(yao)(yao)業集(ji)團(tuan)重慶(qing)禮(li)邦藥(yao)(yao)物(wu)開(kai)發有(you)(you)限(xian)(xian)(xian)公(gong)(gong)(gong)司(si)、2009年(nian)(nian)(nian)7月(yue)(yue)全(quan)(quan)(quan)資(zi)收購的(de)(de)(de)(de)(de)以制劑生(sheng)(sheng)(sheng)產(chan)為(wei)(wei)主營(ying)業務(wu)的(de)(de)(de)(de)(de)福(fu)安(an)(an)藥(yao)(yao)業集(ji)團(tuan)慶(qing)余堂(tang)制藥(yao)(yao)有(you)(you)限(xian)(xian)(xian)公(gong)(gong)(gong)司(si)和主要從(cong)事(shi)藥(yao)(yao)品銷售(shou)業務(wu)的(de)(de)(de)(de)(de)重慶(qing)生(sheng)(sheng)(sheng)物(wu)制品有(you)(you)限(xian)(xian)(xian)公(gong)(gong)(gong)司(si)、2011年(nian)(nian)(nian)8月(yue)(yue)全(quan)(quan)(quan)資(zi)控(kong)股(gu)(gu)以制劑生(sheng)(sheng)(sheng)產(chan)為(wei)(wei)主營(ying)業務(wu)的(de)(de)(de)(de)(de)福(fu)安(an)(an)藥(yao)(yao)業集(ji)團(tuan)湖北人民制藥(yao)(yao)有(you)(you)限(xian)(xian)(xian)公(gong)(gong)(gong)司(si)、2013年(nian)(nian)(nian)8月(yue)(yue)20日控(kong)股(gu)(gu)子公(gong)(gong)(gong)司(si)福(fu)安(an)(an)藥(yao)(yao)業集(ji)團(tuan)重慶(qing)凱斯特(te)醫(yi)藥(yao)(yao)有(you)(you)限(xian)(xian)(xian)公(gong)(gong)(gong)司(si)、2014年(nian)(nian)(nian)3月(yue)(yue)全(quan)(quan)(quan)資(zi)控(kong)股(gu)(gu)的(de)(de)(de)(de)(de)從(cong)事(shi)醫(yi)藥(yao)(yao)中間體(ti)生(sheng)(sheng)(sheng)產(chan)的(de)(de)(de)(de)(de)廣安(an)(an)凱特(te)制藥(yao)(yao)有(you)(you)限(xian)(xian)(xian)公(gong)(gong)(gong)司(si)、2015年(nian)(nian)(nian)5月(yue)(yue)全(quan)(quan)(quan)資(zi)控(kong)股(gu)(gu)的(de)(de)(de)(de)(de)福(fu)安(an)(an)藥(yao)(yao)業集(ji)團(tuan)寧波天衡(heng)制藥(yao)(yao)有(you)(you)限(xian)(xian)(xian)公(gong)(gong)(gong)司(si)、2016年(nian)(nian)(nian)6月(yue)(yue)全(quan)(quan)(quan)資(zi)控(kong)股(gu)(gu)的(de)(de)(de)(de)(de)煙臺只楚藥(yao)(yao)業有(you)(you)限(xian)(xian)(xian)公(gong)(gong)(gong)司(si)、2016年(nian)(nian)(nian)9月(yue)(yue)從(cong)集(ji)團(tuan)公(gong)(gong)(gong)司(si)剝離成立的(de)(de)(de)(de)(de)福(fu)安(an)(an)藥(yao)(yao)業集(ji)團(tuan)重慶(qing)博圣制藥(yao)(yao)有(you)(you)限(xian)(xian)(xian)公(gong)(gong)(gong)司(si)。

公(gong)司(si)主要從事原料藥(yao)及(ji)制劑的(de)生產、銷售。目前公(gong)司(si)主要涉(she)及(ji)的(de)領域有抗(kang)(kang)感染(ran)、抗(kang)(kang)腫瘤(liu)、精神神經系(xi)統、心腦血(xue)管、消化系(xi)統、內分泌(mi)及(ji)代謝、骨骼與肌肉系(xi)統等。

集團公(gong)司現(xian)有職工(gong)1900余人，其中博士(shi)5名，碩士(shi)48名，本科學歷404人，人才梯次和(he)結構(gou)合理(li)。公(gong)司將積極(ji)推進(jin)產(chan)(chan)(chan)品(pin)(pin)結構(gou)的(de)優化、加快(kuai)產(chan)(chan)(chan)品(pin)(pin)研(yan)發和(he)科研(yan)成果的(de)產(chan)(chan)(chan)業化，努力完成由抗生素產(chan)(chan)(chan)品(pin)(pin)占據(ju)主導地位(wei)向(xiang)抗生素與專科用藥協同發展(zhan)的(de)戰略調整，為公(gong)司的(de)未來發展(zhan)奠定堅實(shi)基礎。